- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Axitinib
Total 1065 results
-
Boehringer IngelheimApproved for marketingCarcinoma, Non-Small-Cell LungKorea, Republic of
-
Xuzhou Central HospitalUnknownLung Squamous Cell Carcinoma
-
Hebei Medical University Fourth HospitalUnknown
-
Anhui Provincial HospitalUnknownTwo Different Treatment MethodsChina
-
Boehringer IngelheimTerminatedAfatinib in EGFR+NSCLC (Recurrent or Stage IV) - Patients With Poor Performance Status (ECOG 2 or 3)Carcinoma, Non-Small-Cell Lung | ErbB ReceptorsUnited States
-
Groupe Hospitalier Paris Saint JosephWithdrawn
-
Shanghai Zhongshan HospitalUnknownCarcinoma, HepatocellularChina
-
Junling LiUnknownApatinib in Maintenance TreatmentChina
-
Hangzhou Cancer HospitalUnknownEsophageal Cancer | Apatinib | Metastatic Esophageal CancerChina
-
Peking University Cancer Hospital & InstituteJiangsu HengRui Medicine Co., Ltd.UnknownHepatocellular CarcinomaChina
-
First Affiliated Hospital of Zhejiang UniversityNot yet recruitingAdvanced Biliary Tract CarcinomaChina
-
Shandong UniversityThe Affiliated Hospital of Qingdao University; Qianfoshan Hospital; The Second...Recruiting
-
Yousef ZakhariaPfizerActive, not recruitingAdvanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC)United States
-
Lei ZHAORecruitingIntrahepatic CholangiocarcinomaChina
-
Guangdong Provincial People's HospitalCompletedTriple-Negative Breast CancerChina
-
Fudan UniversityCompletedEsophageal NeoplasmsChina
-
Boehringer IngelheimCompleted
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityCompleted
-
Peking University People's HospitalJiangsu HengRui Medicine Co., Ltd.CompletedToxicity | Overall Survival | Progression-free Survival | Clinical Benefit RateChina
-
Shanghai Chest HospitalUnknownLung Squamous Cell CarcinomaChina
-
Peking UniversityUnknown
-
Anhui Provincial HospitalUnknown
-
Boehringer IngelheimApproved for marketingCarcinoma, Non-Small-Cell LungAustralia
-
Virginia SimnadBiogenUnknown
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedBreast NeoplasmsBelgium, Germany
-
Boehringer IngelheimCompletedNeoplasmsUnited Kingdom
-
Sorrento Therapeutics, Inc.Completed
-
Samsung Medical CenterNot yet recruitingThymic Epithelial TumorKorea, Republic of
-
Huiqiang HuangRecruitingDiffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | Transformed Lymphoma | EBV-Positive DLBCL, Nos | ALK-Positive Anaplastic Large Cell Lymphoma | Follicular Lymphoma Grade IIIbChina
-
Anhui Provincial HospitalNot yet recruiting
-
Chonnam National University HospitalCompletedLung Neoplasms | EGFR Gene MutationKorea, Republic of
-
Seoul St. Mary's HospitalBoehringer IngelheimActive, not recruiting
-
The First Hospital of Jilin UniversityCompleted
-
Fondation Ophtalmologique Adolphe de RothschildTerminatedMonitoring of Patients Followed for a Multiple Sclerosis and Treated by Dimethyl-fumarate (SURV-SEP)Multiple Sclerosis, Relapsing-RemittingFrance
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungSerbia, Thailand, Poland, Romania, Egypt, Philippines, Malaysia
-
Shanghai Zhongshan HospitalUnknownHepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization
-
Hebei Medical UniversityJiangsu HengRui Medicine Co., Ltd.Unknown
-
Elevar TherapeuticsBukwang Pharmaceutical, Co., Ltd.CompletedCancer Patients With Solid TumorsKorea, Republic of, United States
-
Beijing Friendship HospitalUnknown
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
First Affiliated Hospital Xi'an Jiaotong UniversityUnknownPancreatic NeoplasmsChina
-
Boehringer IngelheimCompletedLiver Diseases | HealthyGermany
-
Shenzhen People's HospitalUnknownGastrointestinal Neoplasms | Digestive System Neoplasms | Colorectal Neoplasms | Intestinal NeoplasmsChina
-
Dana-Farber Cancer InstitutePfizerActive, not recruiting
-
Ramathibodi HospitalCompletedH Pylori EradicationThailand
-
Peking UniversityRecruitingEsophageal Squamous CarcinomaChina
-
West China HospitalRecruiting
-
Leiden University Medical CenterBoehringer Ingelheim; Chordoma FoundationActive, not recruiting